大麻検査の世界市場規模、シェア、成長分析、技術別、検査別、エンドユーザー別-産業予測、2023～2030年

世界の大麻試験市場規模は2022年に70億米ドルと評価され、2023年の79億米ドルから2031年には219億米ドルに成長し、予測期間（2024～2031年）のCAGRは13.5%で成長する展望です。

世界の大麻試験市場は、大麻の生産量と普及率の増加とともに、さまざまな神経疾患や精神疾患の治療における大麻抽出物の使用により、急速な拡大を経験しています。予測期間中、この増加傾向は大麻試験市場に大きな拡大をもたらすと予測されます。European Brain Councilの推定によると、世界全体で約600の神経学的異常が登録されており、精神疾患は世界中で病気や障害の主要原因の一つとなっています。うつ病は世界で最も一般的な精神疾患であり、あらゆる年齢層の2億6,400万人以上が罹患しており、女性の罹患率が高いです。大麻試験は、大麻ベースの医薬品の安全性と有効性を評価するために重要です。さらに、大麻研究所におけるソフトウェアサービスの受け入れと認知が拡大しています。

目次

エグゼクティブサマリー

• 市場概要
• 繁栄と衰退

調査手法

• 情報調達
• セカンダリとプライマリデータソース
• 市場規模の推定
• 市場の前提条件と制限

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要市場の考察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーションマトリクス
• パイプライン製品の分析
• マクロ経済指標
• 主要投資の分析
• 主要成功要因
• 競合の程度

市場力学と展望

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制情勢
• ポーターの分析
• 将来の混乱についての特別な考察

大麻試験の世界市場：技術別

• 市場概要
• クロマトグラフィー
• 液体クロマトグラフィー
• ガスクロマトグラフィー
• 分光法
• 質量分析法
• 原子分光法
• その他

大麻試験の世界市場：試験別

• 市場概要
• 効力試験
• 農薬スクリーニング
• 残留溶媒のスクリーニング
• 重金属試験
• テルペン試験
• マイコトキシン試験
• その他

大麻試験の世界市場：エンドユーザー別

• 市場概要
• 研究室
• 大麻栽培者と栽培者
• 大麻医薬品の製造業者と薬局
• その他

大麻試験の世界市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2021年）
• 主要市場企業が採用した戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア（2021年）

主要企業プロファイル

• Shimadzu Scientific Instruments
• Agilent Technologies Inc.
• Danaher Corporation
• Accelerated Technology Laboratories Inc.
• Merck KGaA（Sigma Aldrich）
• Pharmlabs LLC
• Restek Corporation
• Sartorius AG
• Steep Hill Halent Laboratories Inc.
• PerkinElmer Inc.
• Digipath Inc.
• AB Sciex Pte. Ltd

Global Cannabis Testing Market size was valued at USD 7 billion in 2022 and is poised to grow from USD 7.9 billion in 2023 to USD 21.9 billion by 2031, growing at a CAGR of 13.5% during the forecast period (2024-2031).

The Global Cannabis Testing Market is experiencing rapid expansion owing to the use of cannabis extracts in the treatment of various neurological and mental conditions, in tandem with the growth in cannabis production and prevalence. Over the course of the forecast period, this increasing tendency is anticipated to create significant expansion in the cannabis testing market. The European Brain Council estimates that there are about 600 neurological abnormalities registered globally, making mental illnesses one of the main causes of illness and impairment worldwide. Depression is the most common mental illness worldwide, affecting over 264 million people of all ages, with a higher incidence in women. Cannabis testing is important for assessing the safety and effectiveness of cannabis-based medicines, as seen by its increasing prevalence. Furthermore, the growing acceptance and recognition of software services in cannabis research laboratories.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cannabis Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cannabis Testing Market Segmental Analysis

The global cannabis testing market is segmented into three segments i.e. by technology, test and region. Based on Technology the market is segmented as, chromatography, gas chromatography, spectroscopy, liquid chromatography, atomic spectroscopy, mass spectrometry and others. Based on end user the market is segmented as, laboratories, cannabis cultivators and growers, cannabis drug manufacturers and dispensaries, and other end users. Based on test the market is segmented as, potency testing, pesticide screening, residual solvent screening, heavy metal testing, terpene testing, mycotoxin testing, and others. Based on regions the market is segmented as, North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

Drivers of the Global Cannabis Testing Market

One of the major drivers of this market is the legalization of medical cannabis along with the rise in number of cannabis testing laboratories worldwide. With its ability to reduce symptoms and improve patients' quality of life, medical cannabis has emerged as a promising treatment option for a wide range of illnesses. Its noteworthy effects include reducing nausea from chemotherapy, promoting appetite in AIDS patients, and controlling spasms in the muscles of people with multiple sclerosis. These claims are backed by a wealth of evidence.

Restraints in the Global Cannabis Testing Market

The lack of standardized testing methodologies poses a significant obstacle to the growth of the cannabis testing sector. The absence of consistency in testing protocols creates a significant obstacle, particularly with respect to the accurate dosage of cannabis meant for therapeutic use. The reliability and consistency of cannabis-based pharmaceuticals are seriously compromised by the scattered nature of quality standards that are in place across different states.

Market Trends of the Global Cannabis Testing Market

Strong government support for the legalization of medical marijuana in these areas is what is fueling this expansion. Investors, significant business players, and governmental organizations are drawn to this supporting posture toward medical cannabis legalization as they look for possibilities to invest in expanding the infrastructure for cannabis testing.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Cannabis Testing Market by Technology

• Market Overview
• Chromatography
• Liquid chromatography
• Gas chromatography
• Spectroscopy
• Mass spectrometry
• Atomic spectroscopy
• and Others

Global Cannabis Testing Market by Test

• Market Overview
• Potency Testing
• Pesticide Screening
• Residual Solvent Screening
• Heavy Metal Testing
• Terpene Testing
• Mycotoxin Testing
• and Others

Global Cannabis Testing Market by End User

• Market Overview
• Laboratories
• Cannabis Cultivators and Growers
• Cannabis Drug Manufacturers and Dispensaries
• and Others

Global Cannabis Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Shimadzu Scientific Instruments
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerated Technology Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Sigma Aldrich)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmlabs LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Restek Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Steep Hill Halent Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digipath Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AB Sciex Pte. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments